Stock of the Day

Vera Therapeutics (VERA)

$28.58

-$1.03 (-3.5%)

Market Cap: $1.88B

About Vera Therapeutics

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial.

It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Recent News

• Vera Therapeutics selloff a buying opportunity, says Evercore ISI (markets.businessinsider.com)
• Vera Therapeutics pullback a buying opportunity, says Cantor Fitzgerald (markets.businessinsider.com)
• TD Cowen Remains a Buy on Vera Therapeutics (VERA) (markets.businessinsider.com)